Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gemtuzumab ozogamicin: is there room for salvage?

× No keyword cloud information.

6 in total

Review 1. Current status and contemporary approaches to the discovery of antitumor agents from higher plants.

Authors: Garima Agarwal; Peter J Blanco Carcache; Ermias Mekuria Addo; A Douglas Kinghorn
Journal: Biotechnol Adv Date: 2019-01-08 Impact factor: 14.227

2. CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.

Authors: Jatinder K Lamba; Lata Chauhan; Miyoung Shin; Michael R Loken; Jessica A Pollard; Yi-Cheng Wang; Rhonda E Ries; Richard Aplenc; Betsy A Hirsch; Susana C Raimondi; Roland B Walter; Irwin D Bernstein; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal: J Clin Oncol Date: 2017-06-23 Impact factor: 44.544

Review 3. New Technologies Bloom Together for Bettering Cancer Drug Conjugates.

Authors: Yiming Jin; Shahab Edalatian Zakeri; Raman Bahal; Andrew J Wiemer
Journal: Pharmacol Rev Date: 2022-07 Impact factor: 18.923

4. New considerations in the design of clinical trials for the treatment of acute leukemia.

Authors: Christopher S Hourigan; Judith E Karp
Journal: Clin Investig (Lond) Date: 2011-04-01

Review 5. Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin.

Authors: Tetsuya Tanimoto; Masaharu Tsubokura; Jinichi Mori; Monika Pietrek; Shunsuke Ono; Masahiro Kami
Journal: Invest New Drugs Date: 2012-09-11 Impact factor: 3.850

6. A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia.

Authors: Dina Schneider; Ying Xiong; Peirong Hu; Darong Wu; Weizao Chen; Tianlei Ying; Zhongyu Zhu; Dimiter S Dimitrov; Boro Dropulic; Rimas J Orentas
Journal: Front Oncol Date: 2018-11-22 Impact factor: 6.244

6 in total